[go: up one dir, main page]

MX2012014096A - Métodos para mejorar el diagnóstico de enfermedad intestinal inflamatoria. - Google Patents

Métodos para mejorar el diagnóstico de enfermedad intestinal inflamatoria.

Info

Publication number
MX2012014096A
MX2012014096A MX2012014096A MX2012014096A MX2012014096A MX 2012014096 A MX2012014096 A MX 2012014096A MX 2012014096 A MX2012014096 A MX 2012014096A MX 2012014096 A MX2012014096 A MX 2012014096A MX 2012014096 A MX2012014096 A MX 2012014096A
Authority
MX
Mexico
Prior art keywords
inflammatory bowel
bowel disease
methods
disease diagnosis
improving inflammatory
Prior art date
Application number
MX2012014096A
Other languages
English (en)
Inventor
Sharat Singh
Fred Princen
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2012014096A publication Critical patent/MX2012014096A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención proporciona métodos y sistemas para diagnosticar la colitis ulcerosa (UC), subtipo de enfermedad inflamatoria intestinal (lBD) al detectar la presencia o ausencia de uno o más alelos variantes en los genes CLI1, MDRI y/o ATG16L1. De forma favorable, con la presente invención, es posible proporcionar un diagnóstico de UC y diferenciar entre UC y enfermedad de Chron (CD) con mayor precisión.
MX2012014096A 2010-06-04 2011-06-03 Métodos para mejorar el diagnóstico de enfermedad intestinal inflamatoria. MX2012014096A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US35183710P 2010-06-04 2010-06-04
US35414110P 2010-06-11 2010-06-11
US39358810P 2010-10-15 2010-10-15
PCT/US2011/039174 WO2011153501A2 (en) 2010-06-04 2011-06-03 Methods for improving inflammatory bowel disease diagnosis

Publications (1)

Publication Number Publication Date
MX2012014096A true MX2012014096A (es) 2013-04-19

Family

ID=45067328

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012014096A MX2012014096A (es) 2010-06-04 2011-06-03 Métodos para mejorar el diagnóstico de enfermedad intestinal inflamatoria.

Country Status (6)

Country Link
US (1) US20130203053A1 (es)
EP (1) EP2576838A4 (es)
JP (1) JP2013528389A (es)
CA (1) CA2801575A1 (es)
MX (1) MX2012014096A (es)
WO (1) WO2011153501A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015168699A1 (en) * 2014-05-02 2015-11-05 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (mruc) requiring colectomy
MX362132B (es) 2011-05-10 2019-01-07 Nestec Sa Metodos para perfilado de actividad de enfermedad para manejo de terapia personalizado.
AU2012325798B2 (en) 2011-10-21 2015-11-26 Société des Produits Nestlé S.A. Methods for improving inflammatory bowel disease diagnosis
ES2771127T3 (es) * 2012-10-05 2020-07-06 Prometheus Biosciences Inc Métodos para predecir y monitorizar la cicatrización de la mucosa
AU2014241552B2 (en) * 2013-03-27 2018-08-16 Genentech, Inc. Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
EP3094973B1 (en) 2013-11-07 2020-07-29 Diagnodus Limited Biomarkers
CN117286238A (zh) * 2016-05-20 2023-12-26 西达-赛奈医疗中心 基于基因的炎性肠病诊断
JP2020523560A (ja) 2017-05-31 2020-08-06 プロメテウス バイオサイエンシーズ インコーポレイテッド クローン病患者の粘膜治癒を評価する方法
SG10202108020VA (en) * 2017-10-16 2021-09-29 Illumina Inc Deep learning-based techniques for training deep convolutional neural networks
US11861491B2 (en) 2017-10-16 2024-01-02 Illumina, Inc. Deep learning-based pathogenicity classifier for promoter single nucleotide variants (pSNVs)
CN108929913A (zh) * 2018-08-21 2018-12-04 潍坊德诺泰克生物科技有限公司 用于检测rs2032582的引物探针组及其应用
JP7607950B2 (ja) * 2019-09-30 2025-01-06 ユニバーシティ・オブ・ケープ・タウン 尿サンプル中において結核の診断を行なうための方法
CN111180012A (zh) * 2019-12-27 2020-05-19 哈尔滨工业大学 一种基于经验贝叶斯与孟德尔随机化融合的基因识别方法
CN116863995B (zh) * 2023-08-29 2024-05-14 北京大学第一医院 Alpk2，itga11，esyt1，cdh17在预测药物出血中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874233A (en) * 1996-04-12 1999-02-23 Cedars-Sinai Medical Center Methods of diagnosing a clinical subtype of Crohn's disease with features of ulcerative colitis
AU2003298703A1 (en) * 2002-11-22 2004-06-18 Emory University Diagnostic tests and methods for diagnosing inflammatory bowel disease
EP1613960B1 (en) * 2003-04-11 2009-06-03 Cedars-Sinai Medical Center Methods of assessing crohn's disease patient phenotype by i2, ompc and asca serologic response
WO2009003274A1 (en) * 2007-06-29 2009-01-08 The Hospital For Sick Children Susceptibility gene for inflammatory bowel disease
KR20110015409A (ko) * 2007-11-29 2011-02-15 제넨테크, 인크. 염증성 장 질환에 대한 유전자 발현 마커
HUE026542T2 (hu) * 2008-02-19 2016-06-28 The Children's Hospital Of Philadelphia Gyermekkori gyulladásos bélbetegség lókuszok azonosítása és eljárások ezek alkalmazásával gyermekkori gyulladásos bélbetegség diagnosztizálására és kezelésére
WO2010120814A1 (en) * 2009-04-14 2010-10-21 Prometheus Laboratories Inc. Inflammatory bowel disease prognostics

Also Published As

Publication number Publication date
US20130203053A1 (en) 2013-08-08
EP2576838A2 (en) 2013-04-10
JP2013528389A (ja) 2013-07-11
EP2576838A4 (en) 2019-05-15
WO2011153501A9 (en) 2012-04-05
CA2801575A1 (en) 2011-12-08
WO2011153501A2 (en) 2011-12-08

Similar Documents

Publication Publication Date Title
MX2012014096A (es) Métodos para mejorar el diagnóstico de enfermedad intestinal inflamatoria.
MX352274B (es) Metodos para mejorar el diagnostico de enfermedad inflamatoria intestinal.
NZ615010A (en) Detection of sleep onset
NZ622924A (en) System and method for supporting an exercise movement
MX2013000917A (es) Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
EP2576833A4 (en) METHOD AND DEVICE FOR THE POINT-OF-CARE DETECTION OF NUCLEIC ACID IN A SAMPLE
MX2013005740A (es) Indicador vaginal para detectar biomarcadores de buena salud.
MY170983A (en) Biomarker assays for detecting or measuring inhibition of tor kinase activity
MX2013002818A (es) Caracteristica de interruptor de golpe ligero y deteccion de intento de violacion con inversion y remocion a base de acelerometro.
CA2840149C (en) Methods and nucleic acids for determining the prognosis of a cancer subject
MY194686A (en) Detection of chromosome interactions
NZ700695A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
FR2984522B1 (fr) Dispositif de detection de la proximite d'un objet, comprenant des photodiodes spad
MX2009011080A (es) Metodo para la determinacion del riesgo del avance de glaucoma.
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2685270A3 (en) Measurement system
PH12017500798A1 (en) Pna probes, kits and methods for detecting human papillomavirus genotypes of human papillomavirus
MX2014000920A (es) Metodo para evaluar la integridad de la pared celular bacteriana.
EP4570924A3 (en) Chromophore-based characterization and detection methods
WO2015070001A3 (en) Compositions and methods for detecting and/or treating inflammation
WO2015070191A3 (en) Systems and methods for detection of genomic variants
WO2013106844A3 (en) Methods and compositions for the treatment and diaginosis of pancreatic cancer
NZ606124A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX2012009908A (es) Ensayos y equipos para la serotipificacion de pseudomas aeruginosa y secuencias de oligonucleotido utiles en dichos metodos y equipos.
MX2016011750A (es) Metodo y aparato para la deteccion de señales de audio.

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: NESTEC S.A.

FA Abandonment or withdrawal